Eldem, MD). Surgitate has two investors: Farplas, leading plastic automotive parts manufacturer in Turkey, and Inovent, Turkey’s first technology commercialization/accelerator and seed funding company. They rely on expertise of Farplas in process development, molding, and painting for the mass scale production of synthetic body parts. Inovent assures that we are well-connected to our potential investors and customers; and handles business and marketing plans.